Key Insights

Highlights

Success Rate

82% trial completion

Published Results

13 trials with published results (8%)

Research Maturity

70 completed trials (41% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.9%

15 terminated out of 169 trials

Success Rate

82.4%

-4.2% vs benchmark

Late-Stage Pipeline

9%

16 trials in Phase 3/4

Results Transparency

19%

13 of 70 completed with results

Key Signals

13 with results82% success15 terminated

Data Visualizations

Phase Distribution

132Total
Not Applicable (63)
P 1 (13)
P 2 (40)
P 3 (11)
P 4 (5)

Trial Status

Completed70
Unknown43
Recruiting20
Terminated15
Not Yet Recruiting8
Active Not Recruiting8

Trial Success Rate

82.4%

Benchmark: 86.6%

Based on 70 completed trials

Clinical Trials (169)

Showing 20 of 20 trials
NCT02441153CompletedPrimary

Timing of Rectal Cancer Resection After Preoperative Chemoradiotherapy

NCT05868226Phase 1Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05856305Phase 2Active Not RecruitingPrimary

SCRT in TNT With or Without Chlorophyllin

NCT07821775Completed

Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers

NCT05496491Not ApplicableRecruitingPrimary

Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

NCT07755124Phase 1Not Yet RecruitingPrimary

Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Treatment of Rectal Cancer: A Randomized Controlled Trial

NCT05009069Phase 2Active Not RecruitingPrimary

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

NCT04926324Phase 1TerminatedPrimary

A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers

NCT03179540Not ApplicableRecruitingPrimary

Non-operative Management for Locally Advanced Rectal Cancer

NCT01408407Phase 2Terminated

Alkagin Paste in the Prevention of Radiation Dermatitis

NCT06204497Not ApplicableCompletedPrimary

The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients

NCT04084249Not ApplicableActive Not Recruiting

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NCT07543848Phase 2Not Yet RecruitingPrimary

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

NCT07522294Not ApplicableActive Not RecruitingPrimary

Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision

NCT06417476Phase 2Active Not RecruitingPrimary

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

NCT04075305Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

NCT07419516CompletedPrimary

MRA Diameter as a Predictor for LLN Metastasis in Rectal Cancer.

NCT07376980Not ApplicableEnrolling By InvitationPrimary

The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer

NCT06426927Not ApplicableCompleted

PeLear CCC: Proyecto Latino Contra Cancer Colorrectal

NCT07346534Not ApplicableEnrolling By Invitation

Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study

Scroll to load more

Research Network

Activity Timeline